Signups look healthy. Trial-to-paid doesn't. This episode explains why that gap is where most product-led growth motions quietly stall. We cover why treating signup volume as a proxy for acquisition success hides the real story. Why a trial with no defined activation milestone can't tell a user three steps from converting apart from one who's already gone. And what it looks like to instrument the path to activation instead of just measuring what happens after.